In addition, alterations in S100A9 abundance have been associated with many clinically relevant inflammatory states, such as autoimmunity (68, 69), cancer (70–72), coronavirus disease 2019 (COVID-19) (73), and aging (74). Here, S100A9 is linked to cancer.